Updated version of this database is available at ThpDB2

Browse result page of THPdb

The total number entries retrieved from this search are 7
ID1423ThPPIDTh1071NamePancrelipasePeptide SequencePancreatic alpha amy Full viewLength1206Functional ClassificationIaDiseaseMetabolic/genetic/BrandViokaceCompanyAptalis Pharma US, Inc.Physical AppearanceBeige-white amorphous powder, miscible in water and practically insoluble in alcohol and converted to tablet formRoute of AdministartionOral routeCategoryGastrointestinal Agents and Enzyme Replacement Agents TargetSynaptosomal-associated protein 25,Rho-related GTP-binding protein RhoB, Dietary fat,Dietary protein,Dietary starch
ID1648ThPPIDTh1148NameAliskirenPeptide SequenceN.A.
Full view
Length0Functional ClassificationIIaDiseaseMetabolicBrandTekturnaCompanyPhysicians Total Care, Inc.Physical AppearanceLight-pink, biconvex round tabletRoute of AdministartionOral routeCategoryRenin inhibitor TargetRenin
ID1649ThPPIDTh1148NameAliskirenPeptide SequenceN.A.
Full view
Length0Functional ClassificationIIaDiseaseMetabolicBrandTekturnaCompanyNovartis Pharmaceuticals CorporationPhysical AppearanceLight-pink, biconvex round tabletRoute of AdministartionOral routeCategoryRenin inhibitor TargetRenin
ID1650ThPPIDTh1148NameAliskirenPeptide SequenceN.A.
Full view
Length0Functional ClassificationIIaDiseaseMetabolicBrandTekturna HCTCompanyNovartis Pharmaceuticals CorporationPhysical AppearanceBiconvex, ovaloid film-coated tablets.Route of AdministartionOral routeCategoryRenin inhibitor TargetRenin
ID1651ThPPIDTh1148NameAliskirenPeptide SequenceN.A.
Full view
Length0Functional ClassificationIIaDiseaseMetabolicBrandTekamloCompanyNovartis Pharmaceuticals CorporationPhysical AppearanceTablets (aliskiren/amlodipine): 150 mg/5 mg, 150 mg/10 mg, 300 mg/5 mg, 300 mg/10 mgRoute of AdministartionOral routeCategoryRenin inhibitor TargetRenin
ID1652ThPPIDTh1148NameAliskirenPeptide SequenceN.A.
Full view
Length0Functional ClassificationIIaDiseaseMetabolicBrandAmturnideCompanyNovartis Pharmaceuticals CorporationPhysical AppearanceTablets (aliskiren/ amlodipine/ HCTZ): 150/5/12.5, 300/5/12.5, 300/5/25, 300/10/12.5, 300/10/25 mg. Route of AdministartionOral routeCategoryRenin inhibitor TargetRenin
ID1653ThPPIDTh1149NameRagweed Pollen ExtractPeptide SequenceN.A.
Full view
Length0Functional ClassificationIIIaDiseaseImmunologicalBrandRagwitekCompanyMerck Sharp & DohmePhysical AppearanceTabletsRoute of AdministartionOral routeCategoryN.A. TargetN.A.